KRT19P6

Across TCGA pan-cancer cohorts, KRT19P6 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated KRT19P6 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher KRT19P6 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated KRT19P6 expression acts as an unfavorable survival marker.

UCEC, KIRP, and MESO are the cancer types where KRT19P6 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Tertile	All	0.105	0.650	<.001	84	view →
KIRP	OS	Tertile	All	0.161	0.904	<.001	72	view →
MESO	OS	Tertile	All	0.018	0.559	<.001	36	view →
LUAD	OS	Tertile	All	0.272	0.685	.007	27	view →
SKCM	OS	Tertile	II,III,IV	0.135	0.399	.012	12	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

KRT19P6–UCEC (DFS)

Open the UCEC breakdown →